WINNIPEG, MANITOBA--(Marketwire - April 14, 2008) - Miraculins Inc. (TSX VENTURE: MOM), a biotechnology company dedicated to the discovery and development of diagnostic tools and therapeutic products for cancer, is pleased to announce that Stephan J. Frost, PhD, has been appointed Director, Research and Development.
